These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 17234896)
1. Loss of the high-affinity pentamidine transporter is responsible for high levels of cross-resistance between arsenical and diamidine drugs in African trypanosomes. Bridges DJ; Gould MK; Nerima B; Mäser P; Burchmore RJ; de Koning HP Mol Pharmacol; 2007 Apr; 71(4):1098-108. PubMed ID: 17234896 [TBL] [Abstract][Full Text] [Related]
2. The diamidine diminazene aceturate is a substrate for the high-affinity pentamidine transporter: implications for the development of high resistance levels in trypanosomes. Teka IA; Kazibwe AJ; El-Sabbagh N; Al-Salabi MI; Ward CP; Eze AA; Munday JC; Mäser P; Matovu E; Barrett MP; de Koning HP Mol Pharmacol; 2011 Jul; 80(1):110-6. PubMed ID: 21436312 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei. Matovu E; Stewart ML; Geiser F; Brun R; Mäser P; Wallace LJ; Burchmore RJ; Enyaru JC; Barrett MP; Kaminsky R; Seebeck T; de Koning HP Eukaryot Cell; 2003 Oct; 2(5):1003-8. PubMed ID: 14555482 [TBL] [Abstract][Full Text] [Related]
4. Uptake of diamidine drugs by the P2 nucleoside transporter in melarsen-sensitive and -resistant Trypanosoma brucei brucei. Carter NS; Berger BJ; Fairlamb AH J Biol Chem; 1995 Nov; 270(47):28153-7. PubMed ID: 7499305 [TBL] [Abstract][Full Text] [Related]
5. Trypanosoma brucei aquaglyceroporin 2 is a high-affinity transporter for pentamidine and melaminophenyl arsenic drugs and the main genetic determinant of resistance to these drugs. Munday JC; Eze AA; Baker N; Glover L; Clucas C; Aguinaga Andrés D; Natto MJ; Teka IA; McDonald J; Lee RS; Graf FE; Ludin P; Burchmore RJ; Turner CM; Tait A; MacLeod A; Mäser P; Barrett MP; Horn D; De Koning HP J Antimicrob Chemother; 2014 Mar; 69(3):651-63. PubMed ID: 24235095 [TBL] [Abstract][Full Text] [Related]
6. Multiple genetic mechanisms lead to loss of functional TbAT1 expression in drug-resistant trypanosomes. Stewart ML; Burchmore RJ; Clucas C; Hertz-Fowler C; Brooks K; Tait A; Macleod A; Turner CM; De Koning HP; Wong PE; Barrett MP Eukaryot Cell; 2010 Feb; 9(2):336-43. PubMed ID: 19966032 [TBL] [Abstract][Full Text] [Related]
7. Changes in properties of adenosine transporters in Trypanosoma evansi and modes of selection of resistance to the melaminophenyl arsenical drug, Mel Cy. Suswam EA; Taylor DW; Ross CA; Martin RJ Vet Parasitol; 2001 Dec; 102(3):193-208. PubMed ID: 11777599 [TBL] [Abstract][Full Text] [Related]
8. Uptake of pentamidine in Trypanosoma brucei brucei is mediated by three distinct transporters: implications for cross-resistance with arsenicals. De Koning HP Mol Pharmacol; 2001 Mar; 59(3):586-92. PubMed ID: 11179454 [TBL] [Abstract][Full Text] [Related]
9. A diamidine-resistant Trypanosoma equiperdum clone contains a P2 purine transporter with reduced substrate affinity. Barrett MP; Zhang ZQ; Denise H; Giroud C; Baltz T Mol Biochem Parasitol; 1995 Jul; 73(1-2):223-9. PubMed ID: 8577330 [TBL] [Abstract][Full Text] [Related]
10. Transport proteins determine drug sensitivity and resistance in a protozoan parasite, Trypanosoma brucei. Munday JC; Settimo L; de Koning HP Front Pharmacol; 2015; 6():32. PubMed ID: 25814953 [TBL] [Abstract][Full Text] [Related]
11. Uptake of pentamidine in Trypanosoma brucei brucei is mediated by the P2 adenosine transporter and at least one novel, unrelated transporter. de Koning HP; Jarvis SM Acta Trop; 2001 Dec; 80(3):245-50. PubMed ID: 11700182 [TBL] [Abstract][Full Text] [Related]
12. Functional analysis of drug resistance-associated mutations in the Trypanosoma brucei adenosine transporter 1 (TbAT1) and the proposal of a structural model for the protein. Munday JC; Tagoe DN; Eze AA; Krezdorn JA; Rojas López KE; Alkhaldi AA; McDonald F; Still J; Alzahrani KJ; Settimo L; De Koning HP Mol Microbiol; 2015 May; 96(4):887-900. PubMed ID: 25708978 [TBL] [Abstract][Full Text] [Related]
13. The biochemical basis of arsenical-diamidine crossresistance in African trypanosomes. Barrett MP; Fairlamb AH Parasitol Today; 1999 Apr; 15(4):136-40. PubMed ID: 10322334 [TBL] [Abstract][Full Text] [Related]
14. The trypanocide diminazene aceturate is accumulated predominantly through the TbAT1 purine transporter: additional insights on diamidine resistance in african trypanosomes. de Koning HP; Anderson LF; Stewart M; Burchmore RJ; Wallace LJ; Barrett MP Antimicrob Agents Chemother; 2004 May; 48(5):1515-9. PubMed ID: 15105099 [TBL] [Abstract][Full Text] [Related]
15. Characterisation of melarsen-resistant Trypanosoma brucei brucei with respect to cross-resistance to other drugs and trypanothione metabolism. Fairlamb AH; Carter NS; Cunningham M; Smith K Mol Biochem Parasitol; 1992 Jul; 53(1-2):213-22. PubMed ID: 1501641 [TBL] [Abstract][Full Text] [Related]
16. Ever-increasing complexities of diamidine and arsenical crossresistance in African trypanosomes. de Koning HP Trends Parasitol; 2008 Aug; 24(8):345-9. PubMed ID: 18599351 [TBL] [Abstract][Full Text] [Related]
17. Trypanosoma brucei: lack of cross-resistance to melarsoprol in vitro by cymelarsan-resistant parasites. Scott AG; Tait A; Turner CM Exp Parasitol; 1997 Jul; 86(3):181-90. PubMed ID: 9225768 [TBL] [Abstract][Full Text] [Related]